3V3E
Crystal Structure of the Human Nur77 Ligand-binding Domain
3V3E の概要
| エントリーDOI | 10.2210/pdb3v3e/pdb |
| 関連するPDBエントリー | 3V3Q |
| 分子名称 | Nuclear receptor subfamily 4 group A member 1, GLYCEROL (3 entities in total) |
| 機能のキーワード | orphan nuclear receptor, transcription |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Nucleus: P22736 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 57766.89 |
| 構造登録者 | |
| 主引用文献 | Zhan, Y.,Chen, Y.,Zhang, Q.,Zhuang, J.,Tian, M.,Chen, H.,Zhang, L.,Zhang, H.,He, J.,Wang, W.,Wu, R.,Wang, Y.,Shi, C.,Yang, K.,Li, A.,Xin, Y.,Li, T.Y.,Yang, J.Y.,Zheng, Z.,Yu, C.,Lin, S.,Chang, C.,Huang, P.,Lin, T.,Wu, Q. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK Nat.Chem.Biol., 8:897-904, 2012 Cited by PubMed Abstract: Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK). The regulation of LKB1 function, however, is still poorly understood. Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation. This Nur77 function is antagonized by the chemical compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites. TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPKα. Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet- and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out. This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases. PubMed: 22983157DOI: 10.1038/nchembio.1069 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.06 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






